A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)

Inclusion Criteria

• •Diabetes mellitus
• •Hypertension and has received losartan 50 mg or losartan 100 mg for at least 6 months
• •Microalbuminuria (defined as microalbuminuria \> 30 mg/g and \< 300 mg/g by spot urine test)
• •Serum creatinine ≤1.5 mg/dL for men and ≤1.4mg/dL for women
• •Urinalysis with white blood cells (WBC) \<5 cells per high power field
• •Results of hemoglobin A1c (HbA1c), fasting blood glucose, serum creatinine, urine albumin/urine creatinine ratio and urinary analysis tests at baseline and 6 months after initiating the losartan therapy are available
• •Medical history and co-morbidities (if available) listed in medical records
• •Prescription information of antihypertensive regimen of losartan 50 mg or 100 mg available